patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
ATROPINE SULFATE
Marketedupdated 2mo agoby Paragon BioTeck, Inc.
Approvedcommunity read0 votes
all catalysts(12)
approval · 12
Sep 29, 2020
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Oct 6, 2020
approval
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (ATROPINE SULFATE) — FDA approval
ATROPINE SULFATE
→
Jul 26, 2021
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Nov 26, 2021
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Nov 23, 2022
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Apr 7, 2023
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Feb 18, 2025
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Oct 24, 2025
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Feb 4, 2026
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Mar 9, 2026
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Mar 18, 2026
approval
ATROPINE SULFATE — FDA approval
ATROPINE SULFATE
→
Mar 27, 2026
approval
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (ATROPINE SULFATE) — FDA approval
ATROPINE SULFATE
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that